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Abstract
The piglets examined suffer from rickets and have symptoms similar to those of classic pseudo vitamin D-deficiency
rickets, type I (PVDRI), including plasma concentrations of 1K,25-dihydroxyvitamin D3 considerably lower than in healthy
control piglets. It has been suggested that the rachitic piglets have a defective renal 1K,25-dihydroxyvitamin D3 production.
The present study shows that partially purified mitochondrial and microsomal cytochrome P450 from kidney and liver of
both rachitic and control animals is able to catalyze 1K-hydroxylation of 25-hydroxyvitamin D3. The renal mitochondrial 1K-
hydroxylase activity was higher in the rachitic piglets whereas the renal microsomal 1K-hydroxylase activity was decreased.
The immunodetectable levels in kidney of a mitochondrial 1K-hydroxylase (CYP27) and a microsomal 1K-hydroxylase
(vitamin D3 25-hydroxylase) were correlated with the 1K-hydroxylase activities. The results suggest that the renal microsomal
1K-hydroxylase is affected by the rachitic condition. It is concluded that the primary genetic defect of systemic 1K,25-
dihydroxyvitamin D3 deficiency in the rachitic PVDRI piglets does not reside in a defective function or absence of renal
mitochondrial 25-hydroxyvitamin D3 1K-hydroxylase. From this, it may also be concluded that PVDRI in man and pig
appear to be two different forms of the disease. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
1K,25-Dihydroxyvitamin D3 is the hormonally ac-
tive form of vitamin D3. Vitamin D3 is transported
to the liver where it is 25-hydroxylated. 25-Hydrox-
yvitamin D3 is then 1K-hydroxylated mainly in the
kidney. The hydroxylation reactions are catalyzed by
cytochrome P450 enzymes. The important role of
vitamin D for regulating systemic calcium and phos-
phorus homeostasis and for providing normal bone
development is well documented [1]. It has been re-
ported that liver mitochondrial sterol 27-hydroxylase
CYP27, also present in kidney, is able to catalyze not
only 25-hydroxylation of vitamin D3 but also 27-hy-
droxylation and 1K-hydroxylation of 25-hydroxyvita-
min D3 [2^4]. CYP27 puri¢ed from rabbit and pig as
well as human CYP27 expressed in Escherichia coli
or monkey kidney cells, i.e. COS cells, catalyzes 1K-
hydroxylation. Recently, Axe¤n [5] reported the puri-
¢cation from pig kidney of a previously unknown
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microsomal 25-hydroxyvitamin D3 1K-hydroxylase.
Liver microsomal vitamin D3 25-hydroxylase, also
present in kidney, was found to catalyze also 1K-
hydroxylation of 25-hydroxyvitamin D3. It was sug-
gested that microsomal 1K-hydroxylation in kidney
and liver is catalyzed by this enzyme [5]. With this
background we examined the vitamin D3 hydroxy-
lase activities of a rachitic pig strain. In 1962, a dis-
ease was described in pigs showing clinical symptoms
of rickets at weaning. The disease developed despite
a normal dietary supply of vitamin D and resembled
an inherited autosomal recessive form of vitamin D-
responsive rickets [6]. The disease is an inherited au-
tosomal recessive form of vitamin D-responsive rick-
ets in pigs. Results indicate that the animals su¡er
from pseudo vitamin D-de¢ciency rickets type I
(PVDRI) [6^12]. The symptoms are similar to those
of classic vitamin D-de¢ciency rickets and include
hypocalcemia, secondary hyperparathyroidism, im-
paired mineralization and accelerated mobilization
of bone mineral. These piglets usually die at an age
of 6^12 weeks when remaining untreated. They can,
however, e¡ectively be treated with doses of vitamin
D3 that are 20^100 times the physiological daily re-
quirement of approximately 8^10 Wg. Alternatively,
they can be treated and cured with regular physio-
logical doses of 1K,25-dihydroxyvitamin D3, but not
with physiological doses of 25-hydroxyvitamin D3.
It is notable that the 1K,25-dihydroxyvitamin D3 lev-
els in plasma are not zero in the rachitic piglets,
72 pmol/l compared with 169 pmol/l in control pig-
lets [7]. It was demonstrated in an in vitro system
using renal cortex homogenates that no 1K-hydrox-
ylase activity was present in the kidney of rachitic
pigs even in the presence of high concentrations of
25-hydroxyvitamin D3 [13]. This resembles humans
su¡ering from PVDRI [14]. The increase in 25-hy-
droxyvitamin D3 in plasma after treatment with vi-
tamin D3 indicated that the hepatic 25-hydroxylase is
not defective. The possible presence of inhibitor(s) of
1K-hydroxylase in kidney mitochondria of rachitic
pigs has been discussed [11^13].
The aim of this study was to examine the 1K-hy-
droxylase activity towards 25-hydroxyvitamin D3,
and also the 25-hydroxylase activity towards vitamin
D3 in mitochondrial and microsomal cytochrome
P450 fractions, enriched in 1K- and 25-hydroxylase
activity, puri¢ed from kidney and liver of rachitic
and control piglets. Monoclonal antibodies raised
against cytochrome P450 enzymes involved in vita-
min D metabolism have also been used.
2. Materials and methods
2.1. Chemicals
25-Hydroxy[23,24(n)-3H]vitamin D3 (105.5 Ci/
mmol) and 1K,25-dihydroxy-[23,24(n)-3H]vitamin
D3 (91.4 Ci/mmol) were obtained from Amersham
International (Amersham, Bucks., UK). Unlabeled
vitamin D3 and polyoxyethylene 10 lauryl ether (PO-
ELE) were obtained from Sigma Chemical Co. and
unlabeled 25-hydroxyvitamin D3 was from Solvay
Duphar B.V. Hydroxylapatite (Bio-Gel HTP) was
from Bio-Rad and mixed with an equal amount
(w/w) of Whatman CF-1 cellulose powder before
chromatography. Octylamine-Sepharose 4B was pre-
pared by coupling 1,8-diamino-octane to CNBr-
Sepharose 4B from Pharmacia. Sep-Pak, C18, car-
tridges were from Waters Chromatography Division,
Millipore Corporation, USA. Remaining chemicals
were reagent grade.
2.2. Animals
The rachitic animals were homozygous with re-
spect to the rachitic condition. They su¡ered from
an inherited autosomal recessive form of vitamin
D-responsive rickets, PVDRI. The control piglets
were heterozygous litter mates from the same breed.
The piglets, mixed sex, were 8^12 weeks old. The
homozygous piglets were su¡ering from active rickets
when samples were collected. Rickets was diagnosed
by clinical symptoms, the presence of hypocalcemia,
hypophosphatemia, and a marked increase in the
activity of alkaline phosphatase in plasma. After
weaning the animals were maintained on a commer-
cial pig starter diet with 0.8% calcium and 0.6%
phosphorus. The enzyme puri¢cations were done
with kidney and liver samples from 11 homozygous
and seven heterozygous, control piglets. The kidney
and liver samples had been frozen for 3^5 months
before puri¢cation.
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2.3. Enzyme puri¢cation
Partially puri¢ed, enriched, mitochondrial and mi-
crosomal cytochrome P450 was prepared from kid-
ney and liver of healthy control and rachitic animals.
Cytochrome P450 from mitochondria was partially
puri¢ed as described [15] including sonication, solu-
bilization, octylamine-Sepharose chromatography
and hydroxylapatite chromatography. Cytochrome
P450 from microsomes was partially puri¢ed accord-
ing to the initial steps described for isolation of ap-
parently homogeneous microsomal vitamin D3 25-
hydroxylase [16] including solubilization, octyl-
amine-Sepharose chromatography and hydroxylapa-
tite chromatography. Detergent was removed as de-
scribed [15]. Microsomal NADPH-cytochrome P450
reductase from pig liver and mitochondrial ferredox-
in and ferredoxin reductase from bovine adrenals
were puri¢ed as described previously [16,17].
2.4. Incubation procedures
Incubations were performed and analyzed on
HPLC as described previously [4,16]. Incubations
with partially puri¢ed mitochondrial and microsomal
cytochrome P450 contained the speci¢c reductase
components required for catalytic activity, i.e. mito-
chondrial ferredoxin and ferredoxin reductase or mi-
crosomal NADPH-cytochrome P450 reductase, re-
spectively. In one set of control incubations, the
respective reductase components were omitted. In
another, the microsomal reductase was replaced by
the mitochondrial ferredoxin and ferredoxin reduc-
tase and vice versa. The control incubations did
not show 1K- or 25-hydroxylase activities.
2.5. Other methods
Electrophoresis, protein and cytochrome P450 de-
terminations were performed as described previously
[16,18,19]. The statistical signi¢cance of data was
evaluated using two-tailed t-test.
3. Results
3.1. Immunodetectable enzyme concentrations in
mitochondrial and microsomal fractions of kidney
and liver
Initial incubations with the mitochondrial and mi-
crosomal fractions of kidney and liver showed low
25-hydroxylase activity towards vitamin D3 in both
healthy control and rachitic piglets. No 1K-hydroxy-
lation of 25-hydroxyvitamin D3 could be detected
with the analyzing methods used, most likely due
to the fact that the tissues had been frozen for
some months before enzyme analysis. Mitochondrial
CYP27 has been identi¢ed as a 25- and 1K-hydrox-
ylase in liver and has been suggested to be a 1K-
hydroxylase also in kidney [4]. A monoclonal anti-
body raised against pig liver mitochondrial CYP27
Table 1
Hydroxylase activity in partially puri¢ed mitochondrial cytochrome P450 from kidney and livera
25-Hydroxyvitamin D3 Vitamin D3
1K-hydroxylation
(pmol/nmol P450/min)
25-hydroxylation
(pmol/nmol P450/min)
nmol cytochrome P450/mg of protein
Kidney
Healthy control 13.5 þ 2.8 (n = 6) 317.5 þ 94.7 (n = 5) 0.3
Rachitic 38.1 þ 8.5 (n = 6)* 654.1 þ 270.6 (n = 8)*** 0.4
Liver
Healthy control 16.6 þ 6.3 (n = 5) 580.3 þ 19.7 (n = 6) 1.4
Rachitic 19.1 þ 6.5 (n = 5)** 746.6 þ 141.0 (n = 5)**** 1.3
*P6 0.001, **Ps 0.5, ***P6 0.02, ****P6 0.05. A di¡erence in enzyme activity between rachitic and healthy control piglets is inter-
preted as signi¢cant if P6 0.05.
an = number of incubation experiments. Data are given as the means þ S.D. Incubations with the partially puri¢ed mitochondrial cyto-
chrome P450: 0.25 nmol cytochrome P450, 0.4 nmol ferredoxin reductase, 4 nmol ferredoxin, 25 Wg substrate, 1 mg NADPH, in a ¢-
nal incubation volume of 1 ml of 50 mM Tris-acetate, pH 7.4, containing 20% glycerol and 0.1 mM EDTA. Incubations were carried
out for 60 min at 37‡C.
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[3] was therefore used in immunoblot experiments
with mitochondria from each individual animal and
pools of kidney and liver, respectively, from rachitic
and control animals. These results are shown in Fig.
1A. The concentrations of CYP27 in kidney mito-
chondria were much lower than in liver mitochondria
and 5 Wg of kidney mitochondrial protein was not
su⁄cient for detection of the kidney CYP27 [3]. The
results show that there is no apparent big di¡erence
in CYP27 concentration in liver mitochondria be-
tween control and rachitic animals. Apparently ho-
mogeneous preparations of microsomal vitamin D3
25-hydroxylase have recently been found to catalyze
also 1K-hydroxylation [5]. A monoclonal antibody
raised against pig liver microsomal vitamin D3 25-
hydroxylase [16] was used in immunoblot experi-
ments with microsomes from liver and kidney of
each individual animal and from pools of kidney
and liver, respectively, from rachitic and control ani-
mals. The results are shown in Fig. 1B. The healthy
control animals had higher concentrations of kidney
microsomal vitamin D3 25-hydroxylase compared
with the rachitic animals. No di¡erence in concen-
tration of liver microsomal vitamin D3 25-hydroxy-
lase could be seen. There was no detectable cross
reaction between antibodies raised against mitochon-
drial CYP27 and microsomal protein or between
antibodies raised against microsomal vitamin D3
25-hydroxylase and mitochondrial protein.
3.2. Hydroxylase activities and immunodetectable
enzyme concentrations in partially puri¢ed,
enriched, mitochondrial and microsomal
cytochrome P450 from kidney and liver
The mitochondria and microsomes, respectively,
within each group were pooled before further puri¢-
cation. In Tables 1 and 2, the speci¢c cytochrome
P450 content together with the 1K-hydroxylase activ-
ity towards 25-hydroxyvitamin D3 and the 25-hy-
droxylase activity towards vitamin D3 in the partially
puri¢ed fractions are shown. Table 1 shows that
the two mitochondrial hydroxylase activities were
signi¢cantly higher (P6 0.001 and P6 0.02, respec-
tively) in cytochrome P450 puri¢ed from kidneys of
the rachitic animals whereas the activities in cyto-
chrome P450 puri¢ed from liver were only slightly
higher than in the healthy control pigs. The renal
1K-hydroxylase activity towards 25-hydroxyvitamin
D3 was almost three times higher in the mitochon-
Fig. 1. SDS-PAGE and immunoblotting of mitochondria (A) and microsomes (B) from kidney and liver. Immunoblotting with 5 Wg
of protein was performed with a monoclonal antibody as described in Section 2. In (A) a monoclonal antibody raised against liver mi-
tochondrial CYP27 [3] and in (B) a monoclonal antibody against liver microsomal vitamin D 25-hydroxylase [16] was used. Mitochon-
dria (A) or microsomes (B) from: lanes 1^5, livers of rachitic animals; lanes 6^9, livers of healthy control animals; lanes 10^14, kid-
neys of rachitic animals; lanes 15^18, kidneys of healthy control animals; lane 19, pool of livers of rachitic animals; lane 20, pool of
livers of healthy control animals; lane 21, pool of kidneys of rachitic animals; lane 22, pool of kidney of healthy control animals.
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drial cytochrome P450 fraction of rachitic animals
compared with that in control animals. The opposite
relationship was found in partially puri¢ed cyto-
chrome P450 from microsomes (Table 2). The 1K-
hydroxylase activity in kidney microsomal cyto-
chrome P450 from rachitic animals was signi¢cantly
decreased (P6 0.001) compared with the activity of
control animals. The 25-hydroxylase activity was
also signi¢cantly decreased (P6 0.001). There was
no di¡erence in hepatic 1K-hydroxylase activity or
25-hydroxylase activity. It should be mentioned
that the data in Table 2 showing about 65% lower
renal microsomal 1K-hydroxylase activity in rachitic
animals are the mean values obtained from all prep-
arations carried out. However, in one set of prepa-
rations with kidneys from seven rachitic and three
control animals, the decrease was about 90%
(0.34 þ 0.25 pmol/nmol P450/min for rachitic com-
pared with 3.1 þ 0.76 for control animals).
The hydroxylase activities were una¡ected by the
antioxidant 1,2-dianilino ethane (10 WM) and were
almost completely inhibited by 300 WM ketoconazole
(s 80%), in both the mitochondrial and microsomal
cytochrome P450. These results exclude the possibil-
ity that 1K,25-dihydroxyvitamin D3 and 25-hydrox-
yvitamin D3 were formed by nonenzymatic reactions
[20]. A possible contamination of microsomal cyto-
chrome P450 with mitochondrial 1K- and 25-hydrox-
ylases and vice versa can be excluded since replace-
Fig. 2. SDS-PAGE and immunoblotting of partially puri¢ed cy-
tochrome P450 from mitochondria (A) and microsomes (B)
from kidney and liver. Immunoblotting was performed with 0.5
Wg of protein, except for the experiments with kidney microso-
mal cytochrome P450 where 2 Wg was used, and a monoclonal
antibody as described in Section 2. In (A) a monoclonal anti-
body raised against liver mitochondrial CYP27 [3] and in (B) a
monoclonal antibody against liver microsomal vitamin D 25-hy-
droxylase [16] was used. Partially puri¢ed cytochrome P450
from: lane 1, livers of rachitic animals; lane 2, livers of healthy
control animals; lane 3, kidneys of rachitic animals; lane 4,
kidneys of healthy control animals. In (B), the kidney microso-
mal cytochrome P450 preparation from control animals, lane 4,
had about 10-fold higher 1K-hydroxylase activity than that
from rachitic animals, lane 3 (cf. Section 3.2).
Table 2
Hydroxylase activity in partially puri¢ed microsomal cytochrome P450 from kidney and liver
25-Hydroxyvitamin D3 Vitamin D3
1K-hydroxylation
(pmol/nmol P450/min)
25-hydroxylation
(pmol/nmol P450/min)
nmol cytochrome P450/mg of protein
Kidney
Healthy control 2.8 þ 0.6 (n = 9) 10.6 þ 1.2 (n = 7) 1.3
Rachitic 1.0 þ 0.7 (n = 9)* 4.7 þ 1.3 (n = 7)* 1.1
Liver
Healthy control 5.5 þ 1.1 (n = 5) 20.1 þ 8.1 (n = 5) 2.0
Rachitic 5.8 þ 2.6 (n = 5)** 18.9 þ 9.4 (n = 5)** 1.9
n = number of incubation experiments. Data are given as the means þ S.D. Incubations with the partially puri¢ed microsomal cyto-
chrome P450: 0.25 nmol cytochrome P450, 4 units NADPH-cytochrome P450 reductase, 25 Wg substrate, 1 mg NADPH, in a ¢nal in-
cubation volume of 1 ml of 50 mM Tris-acetate, pH 7.4, containing 20% glycerol and 0.1 mM EDTA. Incubations were carried out
for 60 min at 37‡C.
*P6 0.001, **Ps 0.5. A di¡erence in enzyme activity between rachitic and healthy control piglets is interpreted as signi¢cant if
P6 0.05.
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ment of the respective speci¢c reductase components
resulted in no hydroxylase activity (cf. Section 2.4).
The monoclonal antibodies raised against mito-
chondrial CYP27 and microsomal vitamin D3 25-hy-
droxylase were used in immunoblot experiments with
kidney and liver cytochrome P450. Fig. 2A shows
slightly higher concentrations of CYP27 in both kid-
ney and liver mitochondrial cytochrome P450 from
rachitic compared with control animals. Fig. 2B
shows markedly lower concentrations of microsomal
vitamin D3 25-hydroxylase in cytochrome P450 from
kidneys of rachitic animals. There was no di¡erence
in hepatic concentration of this protein. The cyto-
chrome P450 fraction from kidneys of rachitic ani-
mals, shown in Fig. 2B, had about 10 times lower
1K-hydroxylase activity than the fraction from con-
trol animals. Thus, the levels of immunodetectable
mitochondrial CYP27 and microsomal vitamin D3
25-hydroxylase, both active in 1K-hydroxylation,
were correlated with the 1K-hydroxylase activities
identi¢ed in the fractions.
3.3. Studies on the possible presence of an enzymatic
inhibitor in kidney homogenates from rachitic
animals
One hypothesis which has been suggested to ex-
plain the rachitic condition of the PVDR 1 pigs is
the presence of a renal mitochondrial 1K-hydroxylase
inhibitor(s) [13]. To investigate this possibility, di¡er-
ent amounts of kidney homogenates were added to
the partially puri¢ed cytochrome P450 from kidney
mitochondria. Three concentrations of homogenate
(0.1, 0.5 and 1 mg) from either rachitic or control
animals were added to mitochondrial cytochrome
P450 from kidney of rachitic and control animals,
respectively. This resulted in increased activities, up
to 50%. No di¡erences could be seen between addi-
tion of homogenate from rachitic or control animals
(data not shown).
4. Discussion
Previous studies have shown that piglets with
PVDRI have reduced concentration of 1K,25-dihy-
droxyvitamin D3 but higher concentration of 25-hy-
droxyvitamin D3 in plasma than control animals [7].
In the present communication, we have studied the
possible enzyme sources for 1K,25-dihydroxyvitamin
D3 production, i.e. mitochondrial and microsomal
enzymes of kidney and liver [1^5], and compared
1K- and 25-hydroxylase activities and concentrations
of homozygous, rachitic piglets with those of control
piglets. In the original subcellular fractions, Western
blots were performed using monoclonal antibodies
directed against two enzymes reported to be active
in 1K-hydroxylation, i.e. mitochondrial CYP27 [4]
and microsomal vitamin D3 25-hydroxylase [5]. No
1K-hydroxylase activity could be detected in the mi-
tochondria and microsomes most likely due to the
fact that the kidneys and livers had been frozen for
some months before enzyme analysis. It is known
that hydroxylations cannot be detected in mitochon-
dria after freezing and thawing possibly due to loss
of ferredoxin or to loss of activity of the energy-de-
pendent transhydrogenase. In partially puri¢ed, cy-
tochrome P450-enriched fractions, Western blots
were made in parallel with activity determinations
in presence of added ferredoxin and ferredoxin re-
ductase. The results of the present study show that
piglets with PVDRI have considerable capacity to
catalyze not only 25-hydroxylation but also 1K-hy-
droxylation. The mitochondrial 25-hydroxylase ac-
tivity and concentration of 25-hydroxylating CYP27
were higher in liver and kidney from rachitic ani-
mals. This observation is in agreement with the high-
er circulating levels of 25-hydroxyvitamin D3 found
in rachitic piglets as compared with control animals.
It should be pointed out that after weaning, both the
homozygous and the heterozygous control piglets re-
ceived the same pig starter diet having the same cal-
cium and vitamin D3 content. Therefore, it is appa-
rent that the increased 25-hydroxyvitamin D3 levels
should be determined by the increased liver mito-
chondrial 25-hydroxylase activity. The ¢nding sug-
gests that CYP27 is important for 25-hydroxyvitamin
D3 production in the rachitic piglets. The present
results do not, however, permit an evaluation regard-
ing the relative roles of mitochondrial CYP27 and
microsomal vitamin D3 25-hydroxylase in the forma-
tion of 25-hydroxyvitamin D3 in liver under physio-
logical conditions.
In addition to renal mitochondrial and microsomal
1K-hydroxylase activity, the presence of extrarenal
mitochondrial and microsomal 1K-hydroxylase activ-
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ity was demonstrated in liver of rachitic piglets. The
activities in the control piglets were similar to those
found in recent studies with non-rachitic adult pigs
[4,5]. This apparent over-capacity to catalyze 1K- and
25-hydroxylation could explain the ¢nding that the
1K,25-dihydroxyvitamin D3 concentration is not zero
but a third of that in control pigs [7]. From studies
with humans and rats it has been concluded that the
kidney is the most important source of 1K,25-dihy-
droxyvitamin D3 formation [1,20]. Hepatic 1K-hy-
droxylation of 25-hydroxyvitamin D3 was ¢rst dem-
onstrated by Hollis [28]. The physiological
signi¢cance of hepatic 1K-hydroxylation has not
been fully assessed [28].
According to current concepts, renal 1K-hydroxy-
lation is catalyzed by a speci¢c mitochondrial cyto-
chrome P450 [1,21^27]. Very recently, the isolation of
cDNA encoding mouse [29], rat [30,31] and human
[32] kidney 25-hydroxyvitamin D3 1K-hydroxylase
was reported. The sequences have a high degree of
identity, and a high degree of similarity to CYP27. In
fact, the enzyme has been reported to constitute a
new subfamily of CYP27 [31]. A speci¢c mitochon-
drial 1K-hydroxylase enzyme has, however, not yet
been puri¢ed from pig kidney and characterized. As
mentioned above, both mitochondrial [33] and mi-
crosomal [5] 25-hydroxyvitamin D3 1K-hydroxylases
have been puri¢ed from pig kidney. Thus, multiple
1K-hydroxylases are apparently present in pig kid-
ney. Winkler et al. [13] previously reported the ab-
sence of 25-hydroxyvitamin D3 1K-hydroxylase activ-
ity in crude preparations of renal cortex homogenate
in this rachitic pig strain. A defective mitochondrial
1K-hydroxylation would give a possible explanation
for the reduced 1K,25-dihydroxyvitamin D3 concen-
tration. However, the present results with partially
puri¢ed and enriched kidney mitochondrial cyto-
chrome P450 did not show decreased 1K-hydroxylase
activity in rachitic animals compared with control
animals. The puri¢cation procedures that have been
used are considered to enrich both CYP27 and the
major part of the 1K-hydroxylase activity in pig kid-
ney mitochondria [33]. Studies with a monoclonal
antibody raised against liver mitochondrial CYP27,
which is able to catalyze 1K-hydroxylation and is
present also in kidney [4], did not demonstrate de-
creased levels of this enzyme in either kidneys or liver
of rachitic animals.
The results of the present study show that renal
mitochondrial 1K-hydroxylase(s) can be puri¢ed
from rachitic piglets in larger amounts and with the
same activity as from control pigs. The reduced plas-
ma levels of 1K,25-dihydroxyvitamin D3 in the ra-
chitic animals therefore appear not to be due to ab-
sence or reduced levels of renal mitochondrial 1K-
hydroxylase enzyme(s). The cytochrome P450 frac-
tions analyzed in the present study were prepared
according to procedures considered to enrich the ma-
jor part of the 25-hydroxyvitamin D3 1K-hydroxylase
activity in kidney mitochondria [33]. Although the
possibility cannot be excluded that an important mi-
tochondrial 1K-hydroxylase may have been lost dur-
ing the partial puri¢cation, the results indicate that
the biochemical defect in the rachitic pigs is due to
other causes than lack of renal mitochondrial 1K-
hydroxylase. One possibility which could explain
the reported absence of renal 1K-hydroxylase activity
and reduced plasma concentrations of 1K,25-dihy-
droxyvitamin D3 in the pigs with PVDRI [7,13]
might be the presence of renal 1K-hydroxylase inhib-
itor(s). This possibility appears unlikely, however, as
addition of kidney homogenate from rachitic animals
did not lead to a depression of renal mitochondrial
1K-hydroxylase activity. Another explanation might
be that the rachitic piglets are not de¢cient in the 1K-
hydroxylating cytochrome P450 but have reduced
levels of ferredoxin and/or ferredoxin reductase re-
quired for the 1K-hydroxylase in kidney mitochon-
dria. A de¢ciency in these components would not be
observed in the experiments with puri¢ed cyto-
chrome P450 since ferredoxin and ferredoxin reduc-
tase were added in excess to the incubations. A third
explanation might be that the rachitic condition is
due to reduced levels of another renal 25-hydroxyvi-
tamin D3 1K-hydroxylase. Interestingly, the microso-
mal 1K- and 25-hydroxylase activities in kidney were
signi¢cantly reduced in rachitic animals. This de-
crease in activity was paralleled by a striking de-
crease in immunodetectable kidney microsomal vita-
min D3 25-hydroxylase. Recent results indicate that
this enzyme is also a 1K-hydroxylase [5]. The phys-
iological role and relative contribution of renal mi-
crosomal 1K-hydroxylation to the total 1K,25-dihy-
droxyvitamin D3 production are not yet known. The
decrease in microsomal 1K-hydroxylase activity and
immunodetectable levels of a microsomal 1K-hydrox-
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ylase in kidneys of rachitic pigs is in accordance with
the reduced plasma concentrations of 1K,25-dihy-
droxyvitamin D3 [7]. Whether this decrease is great
enough to explain the reduced 1K,25-dihydroxy-
vitamin D3 levels in the piglets with PVDRI remains
to be established. In any case, the results suggest
that the recently described pig kidney microsomal
1K-hydroxylase [5] is a¡ected by the rachitic condi-
tion.
The aim of this study was to compare the activities
of various mitochondrial and microsomal 1K-hy-
droxylases in kidney and liver of PVDRI piglets,
i.e. of animals which su¡er from inherited 1K,25-di-
hydroxyvitamin D3 de¢ciency and rickets, with those
of control piglets. In conclusion, the results show
that none of the partially puri¢ed 1K-hydroxylases
which may be regarded as possible candidates for
physiological 1K,25-dihydroxyvitamin D3 production
in vivo showed a dramatically lower activity than
that found in control piglets. This ¢nding demon-
strates that this genetic disease is not due to the
virtual absence of any of the pertinent enzymes.
The observation that the renal mitochondrial 25-hy-
droxyvitamin D3 1K-hydroxylase activity was higher
in the rachitic piglets than in normal control piglets
demonstrates that the activity of this enzyme is in
fact capable of responding normally to the hypocal-
cemia which was present in the piglets at the time of
sampling. However, despite this regulatory response
of the enzyme the piglets were unable to produce
su⁄cient amounts of 1K,25-dihydroxyvitamin D3.
This is an important ¢nding per se, underlining the
view that the genetic defect of systemic 1K,25-dihy-
droxyvitamin D3 de¢ciency in the PVDRI piglets
does not reside in a defective function of this enzyme.
From this, it may be concluded that PVDRI in hu-
mans [34] and in piglets are two di¡erent forms of
the disease.
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